Lawsuit Alleges GSK Discontinued Widely Used Flovent Asthma Medication to Avoid Paying Medicaid Rebates
PHOENIX – February 7, 2025 – Arizona Attorney General Kris Mayes, represented by DiCello Levitt, sued pharmaceutical manufacturer GlaxoSmithKline (GSK) for engaging in deceptive and unfair practices that endangered vulnerable asthma patients, especially children, while exploiting taxpayers.
The lawsuit alleges that GSK deliberately discontinued its widely used asthma medication, Flovent, and replaced it with an identical authorized generic as part of a calculated scheme to avoid paying Medicaid rebates tied to years of price inflation.
“GSK put corporate greed ahead of the health and safety of Arizona’s families and children,” said Attorney General Mayes in a press release. “Their manipulation of the system has left countless patients without access to life-saving medication, caused a spike in emergency room visits, and likely contributed to preventable deaths. My office will not stand by while corporations put profit ahead of the health of children.”
“DiCello Levitt is proud to partner with Attorney General Mayes on this critical matter as part of our firm’s efforts to hold corporations accountable for their actions, especially when those actions jeopardize the health and safety of vulnerable populations,” said DiCello Levitt Partner Dan Ferri. “We stand with AG Mayes in her efforts to safeguard the well-being of Arizona’s families and children.”
Read more about how GSK allegedly executed a deliberate scheme to evade its obligations online here. A copy of the complaint is available here.
About DiCello Levitt
At DiCello Levitt, we’re dedicated to achieving justice for our clients through class action, environmental, mass tort, securities, financial services, antitrust, business-to-business, public client, whistleblower, personal injury, and civil and human rights litigation. Our lawyers are highly respected for their ability to litigate and win cases—whether by trial, settlement, or otherwise—for people who have suffered harm, global corporations that have sustained significant economic losses, and public clients seeking to protect their citizens’ rights and interests. Every day, we put our reputations—and our capital—on the line for our clients.
DiCello Levitt has achieved top recognition as Plaintiffs Firm of the Year and Trial Innovation Firm of the Year by the National Law Journal, in addition to its top-tier Chambers and Benchmark ratings. For more information about the firm, including recent trial victories and case resolutions, please visit www.dicellolevitt.com.